| Назив: | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301 |
Аутори: | Cho, Byoung Chul; Ahn, Myung-Ju; Kang, Jin Hyoung; Soo, Ross A.; Reungwetwattana, Thanyanan; Yang, James Chih-Hsin; Cicin, Irfan; Kim, Dong-Wan; Wu, Yi-Long; Lu, Shun;
Lee, Ki Hyeong; Pang, Yong-Kek; Zimina, Anastasia; Fong, Chin Heng; Poddubskaya, Elena; Sezer, Ahmet; How, Soon Hin; Danchaivijitr, Pongwut; Kim, YuKyung; Lim, Yeji; An, Taewon; Lee, Hana; Byun, Hae Mi; Zaric, Bojan   ;
|
Година: | 2023 |
Публикација: | Journal of Clinical Oncology |
ISSN: | 0732-183X Journal of Clinical Oncology Претражи идентификатор |
Тип резултата: | Научни чланак |
Колација: | vol. 41 br. 26 str. 4208-4217 |
DOI: | 10.1200/JCO.23.00515 |
WoS-ID: | 001069556400005 |
Scopus-ID: | 2-s2.0-85170112349 |
PMID: | 37379502 |
URI: | https://enauka.gov.rs/handle/123456789/933671 |
Пројекат: | The authors would like to thank all the patients who participated in this study and their families and caregivers. The authors would also like to thank the physicians and nurses who cared for the patients and the staff at the clinical sites. |
Извор метаподатака: | (Preuzeto iz CrossRef-a) Zarić, Bojan
(Preuzeto iz Nasi u WoS) |
М-категорија: | 21aM21a - Рад у међ. часопису изузетних вредности |
